SARS-CoV-2-Diagnostics

EPI-Dx: Project Website is online

EPI-Dx has now its own project website with an integrated research tool for the efficient search for relevant SARS-CoV variants in dbSNP

Why do some COVID-19 patients have a severe disease progression while other barely show any symptoms?
In the project EPI-Dx – Epidemiological investigation on peptide signatures, immunity, genetic predisposition as well as changes in SARS-CoV-2 – researchers from ATLAS Biolabs GmbH, invent Diagnostica GmbH and Microdiscovery GmbH try to answer this and similar questions, by investigating if genetic variants play a role in the disease progression. For this serological, genetic and PCR-Tests are going to look at the variations in the genomes of both the host and the pathogen.

Learn more about the EPI-Dx project on the Project-Website – there you can also access the research tool designed by the project coordinator Dr. Karsten Heidtke that allows a targeted search of relevant SARS-CoV SNPs.

This project is funded by the Federal Ministry of Education and Research (grant number 03COV21).

FluoResYst

3rd FluoResYst Workshop

imdb News

IMDB auf der DMEA 2024

imdb News

IMDB as member of the MODIATE-BB network

FluoResYst

Second FluoResYst Workshop

imdb News

Long Night of Economy in the Oberhavel region this year in Hennigsdorf and Velten

FluoResYst

Press Release: official Kick-off of the BMBF Project FluoResYst

imdb News

2 Years of IMDB – happy birthday!